Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -61.41% | -52.94% | -24.69% | 13.59% | 127.45% |
| Gross Profit | 205.96% | 218.79% | 235.97% | 30.36% | -27.54% |
| SG&A Expenses | 2.08% | -5.44% | -1.56% | 1.97% | 21.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.04% | -49.08% | -44.28% | -30.64% | 2.19% |
| Operating Income | 139.21% | 133.72% | 125.57% | 43.78% | 17.52% |
| Income Before Tax | 164.62% | 155.62% | 162.50% | 30.29% | 7.84% |
| Income Tax Expenses | -- | -- | -- | -91.70% | -93.40% |
| Earnings from Continuing Operations | 164.60% | 155.60% | 162.47% | 30.54% | 8.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 164.60% | 155.60% | 162.47% | 30.54% | 8.31% |
| EBIT | 139.21% | 133.72% | 125.57% | 43.78% | 17.52% |
| EBITDA | 140.19% | 134.55% | 126.36% | 43.97% | 17.59% |
| EPS Basic | 169.98% | 154.07% | 176.79% | 95.59% | 96.33% |
| Normalized Basic EPS | 137.66% | 128.19% | 132.46% | 92.17% | 94.39% |
| EPS Diluted | 169.74% | 153.85% | 122.18% | 95.97% | 96.54% |
| Normalized Diluted EPS | 137.51% | 128.05% | 128.31% | 92.25% | 94.42% |
| Average Basic Shares Outstanding | 21.76% | 5.53% | 32.20% | 92.26% | 256.16% |
| Average Diluted Shares Outstanding | 21.83% | 5.59% | 27.68% | 82.63% | 224.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |